APVO financials
Aptevo Therapeutics (APVO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
APVO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$26.31M | -$27.54M | -87.27 |
| 2024 | – | – | -$24.60M | -$24.13M | -31460.61 |
| 2023 | – | – | -$28.88M | -$17.41M | -834248.94 |
| 2022 | $3.11M | – | -$28.64M | $8.03M | 920357.84 |
| 2021 | $12.29M | – | -$21.40M | -$28.46M | -3558326.18 |
| 2020 | $4.31M | – | -$27.49M | -$17.75M | -3065905.42 |